Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

In an interview with Dr. Phil, the health secretary offered false information about vaccine oversight and revealed a lack of ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Amid sweeping budget cuts and layoffs, HHS Secretary Robert F. Kennedy Jr. is planning a $20 million ad campaign urging ...

In an interview with Dr. Phil, the Kennedy offered false information about vaccine oversight and revealed a lack of understanding of new drug approvals.

Public health experts worried about the future of vaccination in the US have come together in an unprecedented new initiative ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

This article is authored by Aditya Sharma, head, Process Solutions, India Region, Merck Life Science, New Delhi.